This inventor holds 1 USPTO granted patent and 3 EPO patents. Top assignee: Novo Nordisk A/s. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Helle Aalund Olsen: Innovator in Pharmaceutical Formulations
Introduction
Helle Aalund Olsen is a notable inventor based in Måløv, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of insulin. His innovative work has led to the development of a unique pharmaceutical formulation that enhances the delivery of insulin.
Latest Patents
Helle Aalund Olsen holds one patent titled "Pharmaceutical formulation comprising crystalline insulin and dissolved insulin." This invention provides a pharmaceutical formulation and a method for preparing the formulation, which is crucial for improving insulin therapy for patients.
Career Highlights
Helle Aalund Olsen is associated with Novo Nordisk A/S, a leading global healthcare company specializing in diabetes care and other chronic conditions. His work at Novo Nordisk has positioned him as a key player in the advancement of insulin formulations.
Collaborations
Helle has collaborated with notable colleagues, including Petter Lybeck (Berglund) and Charlotte Hammelev, who is a talented woman in the field. Their teamwork has contributed to the success of various projects within the company.
Conclusion
Helle Aalund Olsen's contributions to pharmaceutical formulations, particularly in insulin delivery, highlight his innovative spirit and dedication to improving patient care. His work continues to influence the field of diabetes treatment and showcases the importance of collaboration in scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile